ABOUT Rifampicin

Rifampicin(INN) or rifampin(USAN) is a bactericidal antibiotic drug of the rifamycin group.It is a semisynthetic compound derived from Amycolatopsis rifamycinica.Rifampicin was introduced in 1967, as a major addition to the cocktail-drug treatment of tuberculosis and inactive meningitis, along with isoniazid, ethambutol, pyrazinamide and streptomycin.Rifampicin is typically used to treat Mycobacterium infections, including tuberculosis and Hansen's disease. It can be used to treat abscesses, as an uncommon complication of BCG vaccination for tuberculosis.
There is no difference between a three to four month regimen of rifampicin and a six to nine month regimen for preventing active tuberculosis in those with HIV-negative latent tuberculosis.The quality of the evidence was however low.

CAS:13292-46-1
Molecular Formula: C43H58N4O12
Molecular Weight: 822.94 g/mol
Specification:1g/5g